Biostax Corp. Files Q3 2024 10-Q
| Field | Detail |
|---|---|
| Company | Biostax Corp. |
| Form Type | 10-Q |
| Filed Date | Apr 11, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Biostax Corp. 10-Q filed for Q3 2024. Check financials.
AI Summary
Biostax Corp. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as Immune Therapeutics, Inc. and TNI BIOTECH, INC., is based in Winter Park, Florida. The filing covers financial data for the third quarter of 2024 and year-to-date, comparing it with the same periods in 2023.
Why It Matters
This filing provides investors with an update on Biostax Corp.'s financial performance and position as of Q3 2024, crucial for understanding the company's operational health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical preparations company, Biostax Corp. operates in a highly regulated and competitive industry, which inherently carries significant risks.
Key Numbers
- 20240930 — Period End Date (Financial reporting period)
- 20240930 — Q3 2024 End Date (Quarterly financial reporting)
- 20230930 — Q3 2023 End Date (Prior year quarterly financial reporting)
Key Players & Entities
- Biostax Corp. (company) — Filer
- Immune Therapeutics, Inc. (company) — Former company name
- TNI BIOTECH, INC. (company) — Former company name
- Winter Park, Florida (location) — Business address
FAQ
What were Biostax Corp.'s total revenues for the nine months ended September 30, 2024?
The filing does not explicitly state total revenues for the nine months ended September 30, 2024, but it does provide financial statement data for the period.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code for Biostax Corp. is 2834, Pharmaceutical Preparations.
When was Biostax Corp. formerly known as Immune Therapeutics, Inc.?
Biostax Corp. was formerly known as Immune Therapeutics, Inc. as of November 3, 2014.
What is the fiscal year end for Biostax Corp.?
The fiscal year end for Biostax Corp. is December 31.
What is the filing date of this 10-Q?
This 10-Q filing was made on April 11, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 11, 2025 regarding Biostax Corp..